Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 56 citations · 20 references
MedicineOncologyPharmacologyChemotherapyImmuno-oncology PharmacotherapyOncology PharmacotherapyHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyAcute Leukemia ChemotherapyAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentEastern Cooperative Oncology Group Performance StatusLeukemia Marrow AssessmentMyeloablative ChemotherapyPretreatmentRefractory Leukemia
We retrospectively reviewed outcomes in 45 previously untreated patients with acute myeloid leukemia (AML) considered unfit for chemotherapy who were treated with 10-day courses of decitabine 20 mg/m(2) daily outside of a clinical trial, with no cut-offs for organ function or performance status (PS). Nineteen had Eastern Cooperative Group performance status (ECOG PS) ≥ 2, and 39 had ≥ 2 comorbidities. Fourteen patients (31%) achieved complete remission (CR) and five (11%) CR with incomplete count recovery, for an overall response rate of 42%, after a median of 2 (range, 1-4) courses. The only pretreatment characteristic that differed significantly between responders and non-responders was percent marrow blasts (median 42% vs. 65%; p = 0.01). Median overall survival was 9.0 months; it was 19.4 and 2.3 months for responders and non-responders, respectively (p < 0.001). Thus 10-day decitabine therapy has efficacy in patients with AML considered unfit for chemotherapy, and may serve as a backbone for the addition of other novel agents.
20
Bruce D. Cheson, John M. Bennett, Thomas Büchner et al. · Journal of Clinical Oncology · 2003 · 2.7K citations
Medicine, Hematology, Oncology +17
David Grimwade, Robert K. Hills, Anthony V. Moorman et al. · Blood · 2010 · 2K citations · Full text
Life Sciences, Hematology, Oncology +16
Decitabine improves patient outcomes in myelodysplastic syndromes
Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld et al. · Cancer · 2006 · 1.5K citations
Medicine, Hematology, Pharmacology +14
Age and acute myeloid leukemia
Frederick R. Appelbaum, Holly Gundacker, David R. Head et al. · Blood · 2006 · 1.3K citations · Full text
Medicine, Hematology, Oncology +12